Ownership

Craig Collard

Insider Reports History

Entity: Individual
Location: C/O Cornerstone Therapeutics Inc., 1255 Crescent Green Drive, Suite 250, Cary, NC
Signature: /s/Kathryn Lester Attorney-in-fact for Craig Collard
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Craig Collard:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
HERON THERAPEUTICS, INC. /DE/	Chief Executive Officer, Director	Restricted Stock Units	557K	$1.47M	$2.64	Jan 31, 2025	Direct
HERON THERAPEUTICS, INC. /DE/	Chief Executive Officer, Director	Common Stock	315K	$831K	$2.64	Jan 19, 2025	Direct
TerrAscend Corp.	Director	Common Shares	645K	$419K	$0.65	Dec 31, 2024	Direct
HERON THERAPEUTICS, INC. /DE/	Chief Executive Officer, Director	Employee Stock Option (Right to Buy)	1.11M			Jan 31, 2025	Direct
TerrAscend Corp.	Director	Share Option (Right to Buy)	150K			Jun 17, 2024	Direct
OPIANT PHARMACEUTICALS, INC.	Director	Common Stock	0		$20.00	Mar 2, 2023	Direct
OPIANT PHARMACEUTICALS, INC.	Director	Stock Option (right to buy)	0		$10.00	Mar 2, 2023	Direct
Sierra Oncology, Inc.	Director	Common Stock	0		$55.00	Jul 1, 2022	Direct
Sierra Oncology, Inc.	Director	Stock Option (right to buy)	0			Jul 1, 2022	Direct

Previous1Next

Showing 1 to 9 of 9 entries

Insider Reports Filed by Craig Collard

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
HRTX	HERON THERAPEUTICS, INC. /DE/	Jan 31, 2025	2	$0	4	Feb 4, 2025	Chief Executive Officer, Director
HRTX	HERON THERAPEUTICS, INC. /DE/	Jan 19, 2025	2	$0	4	Jan 22, 2025	Chief Executive Officer, Director
TSNDF	TerrAscend Corp.	Dec 31, 2024	1	-$46.6K	4	Jan 3, 2025	Director
HRTX	HERON THERAPEUTICS, INC. /DE/	Oct 19, 2024	2	$0	4	Oct 21, 2024	Chief Executive Officer, Director
HRTX	HERON THERAPEUTICS, INC. /DE/	Jul 19, 2024	2	$0	4	Jul 22, 2024	Chief Executive Officer, Director
TSNDF	TerrAscend Corp.	Jun 17, 2024	3	$0	4	Jun 20, 2024	Director
HRTX	HERON THERAPEUTICS, INC. /DE/	Apr 19, 2024	2	$0	4	Apr 19, 2024	Chief Executive Officer, Director
HRTX	HERON THERAPEUTICS, INC. /DE/	Apr 3, 2024	2	$0	4	Apr 5, 2024	Chief Executive Officer, Director
HRTX	HERON THERAPEUTICS, INC. /DE/	Jan 19, 2024	2	$0	4	Jan 19, 2024	Chief Executive Officer, Director
HRTX	HERON THERAPEUTICS, INC. /DE/	Nov 16, 2023	1	$138K	4	Nov 17, 2023	Chief Executive Officer, Director
HRTX	HERON THERAPEUTICS, INC. /DE/	Aug 22, 2023	1	-$1.14K	4	Aug 24, 2023	Chief Executive Officer, Director
TSNDF	TerrAscend Corp.	Jun 22, 2023	1	$0	4	Jun 26, 2023	Director
HRTX	HERON THERAPEUTICS, INC. /DE/	May 22, 2023	1	-$1K	4	May 24, 2023	Chief Executive Officer, Director
HRTX	HERON THERAPEUTICS, INC. /DE/	Apr 3, 2023	3	$0	4	Apr 5, 2023	Chief Executive Officer, Director
OPNT	OPIANT PHARMACEUTICALS, INC.	Mar 2, 2023	6	-$1.12M	4	Mar 3, 2023	Director
HRTX	HERON THERAPEUTICS, INC. /DE/	Feb 22, 2023	0	$0	3	Mar 2, 2023	Director
TSNDF	TerrAscend Corp.	Sep 23, 2022	1	$0	4	Sep 27, 2022	Director
TSNDF	TerrAscend Corp.	Sep 22, 2022	1	$0	4	Sep 26, 2022	Director
SRRA	Sierra Oncology, Inc.	Jul 1, 2022	3	-$743K	4	Jul 1, 2022	Director
TSNDF	TerrAscend Corp.	Jun 27, 2022	2	$0	4	Jun 29, 2022	Director
OPNT	OPIANT PHARMACEUTICALS, INC.	Jun 14, 2022	1	$0	4	Jun 14, 2022	Director
OPNT	OPIANT PHARMACEUTICALS, INC.	Jun 10, 2022	2	$63.3K	4	Jun 13, 2022	Director
OPNT	OPIANT PHARMACEUTICALS, INC.	May 16, 2022	1	$368K	4	May 17, 2022	Director
OPNT	OPIANT PHARMACEUTICALS, INC.	May 13, 2022	1	$38.7K	4	May 16, 2022	Director
TSNDF	TerrAscend Corp.	Jan 6, 2022	2	$134K	4	Jan 10, 2022	Director
TSNDF	TerrAscend Corp.	Jan 1, 2022	0	$0	3	Jan 3, 2022	Director
SRRA	Sierra Oncology, Inc.	Nov 23, 2021	2	$311K	4	Nov 24, 2021	Director
OPNT	OPIANT PHARMACEUTICALS, INC.	Sep 13, 2021	3	$67.1K	4	Sep 15, 2021	Director
OPNT	OPIANT PHARMACEUTICALS, INC.	Sep 10, 2021	1	$174K	4	Sep 13, 2021	Director
OPNT	OPIANT PHARMACEUTICALS, INC.	Jun 15, 2021	2	$0	4	Jun 16, 2021	Director
SRRA	Sierra Oncology, Inc.	Jun 8, 2021	1	$0	4	Jun 9, 2021	Director